Target intelligence / Profile preview

Bioactive glass (BAG)

Target
BAG
Molecular classification
Other (Biomaterial), Ceramic, Glass-ceramic
01

Overview

Bioactive glasses are a class of synthetic silica-based biomaterials designed to induce a specific biological response at the interface of the material, resulting in the formation of a bond between the tissues and the material (Hench, 2006, Journal of Materials Science: Materials in Medicine). Originally developed in 1969 as 45S5 Bioglass, these materials are characterized by their ability to release ions such as calcium, phosphorus, and silicon upon contact with physiological fluids (Jones, 2013, Acta Biomaterialia). This ion release triggers the formation of a hydroxycarbonate apatite (HCA) layer, which is chemically and structurally similar to the mineral phase of bone, allowing for seamless integration with host tissue (Rahaman et al., 2011, Acta Biomaterialia). Beyond their osteoconductive properties, bioactive glasses are known to stimulate osteoblast differentiation and promote angiogenesis by upregulating growth factors like VEGF (Gorustovich et al., 2010, Tissue Engineering Part B: Reviews). They also exhibit inherent antimicrobial properties due to the local increase in pH and osmotic pressure caused by ion exchange (Drago et al., 2018, BMC Infectious Diseases). In clinical practice, they are used as bone graft substitutes, dental fillers, and scaffolds for tissue engineering, often serving as delivery vehicles for antibiotics or growth factors.

Other names
Bioglass45S5S53P4Bioactive glass-ceramicSurface-reactive glassCalcium phosphosilicate glass
02

Mechanism of action

Bioactive glass functions through a series of surface reactions including ion exchange (release of Ca2+, PO43-, and Si4+ ions) and the formation of a silica-rich layer, which leads to the precipitation of a hydroxycarbonate apatite (HCA) layer that chemically bonds with host bone and stimulates osteogenic gene expression (Hench, 2006, Journal of Materials Science: Materials in Medicine).

03

Biological functions

OsteoconductionOsteoinductionAngiogenesisMineralizationAntimicrobial activityCell proliferation
04

Disease associations

Bone defectDental cariesPeriodontitisOsteomyelitisSkin woundBone fracture
05

Safety considerations

Local pH increase (alkalinity)Inflammatory response to small particulatesBrittleness and low fracture toughnessPotential for ectopic calcification
06

Interacting drugs

Bone morphogenetic protein 2 (BMP-2)

4 more in the full profile.

07

Biomarkers

Alkaline phosphatase (ALP)OsteocalcinHydroxycarbonate apatite (HCA) layer formationVascular endothelial growth factor (VEGF)

Beyond the preview

Go deeper on Bioactive glass (BAG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioactive glass (BAG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call